-
AI, Machine Learning & Computational Biology6 months agoSTAT+: A 2023 health AI bet that seems to be paying off
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: Sarepta Therapeutics shares rise on early promise for rare disease drugs
Sarepta Therapeutics’ next crop of medicines for muscular dystrophy appear to be safe and effective in early clinical trials, the company said, a positive though incremental...
-
AI, Machine Learning & Computational Biology6 months ago
Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
Merck and Terns Pharmaceuticals have agreed to a $6.7 billion all-cash buyout that delivers a prized leukemia asset to the New Jersey Big Pharma.Read More
-
AI, Machine Learning & Computational Biology6 months agoOpinion: We’re launching a new CMS pilot program to help children with complex conditions
Our public health programs are failing the children who need them most. Together, Medicaid and the Children’s Health Insurance Program (CHIP) cover half of all children...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access
The Federal Trade Commission reached a proposed settlement with CVS Caremark, one of the largest pharmacy benefit managers in the U.S., over allegations the company artificially...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds
Pharmaceutical companies that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs that were the focus of the alleged violations...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug
Patrick Soon-Shiong, a controversial figure in the biotech industry, was harshly criticized by the U.S. Food and Drug Administration for making several false and misleading claims...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: How will Trump handle the CDC and ACIP?
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: The intersection of ‘Apprentice’ and the No Surprises Act
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Spring break is here, and our family is road tripping to...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: Epic says it has uncovered rot in patient record sharing. Will HHS act?
In a recent court filing, electronic health records giant Epic Systems proved one of health care providers’ worst fears: Companies are posing as providers to gain...
Carbon Dots Emerge as a Powerful Weapon Against Superbugs and Biofilms
Your Zip Code May Shape Your Breast Cancer Tumor’s Genetics and Your Survival Odds
Azithromycin Resistance in Gonorrhea Shifts Genetic Ground, Challenging Molecular Surveillance
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
